Autopsy report · NCT01145326

Functional Microarray Augmentation of Skin Treatment With Lidocaine

“The device is undergoing further study in China, per FDA requirements.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2, Phase 3

Sponsor

University of Oklahoma

Sponsor type

University, hospital or other

Conditions

Pain Perception; Phlebotomy

Interventions

4% lidocaine gel application with sham microneedle device; Microneedle-facilitated lidocaine application

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Electrical Impedence Tomography With ENLIGHT2100
  “Device received FDA approval” (68% match in meaning)
• Safety of SP-420 in the Treatment of Transfusional Iron Overload
  “Study is on hold by FDA in the US.” (64% match in meaning)
• BreathID Multi-center HCV Liver Breath Test Study
  “Due to FDA comments, protocol changed; new trial will be proposed shortly” (60% match in meaning)
• Vertebral Body Tethering Treatment for Idiopathic Scoliosis
  “Device is no longer investigational. It has been approved by the FDA as an HUD under HDE H190005.” (56% match in meaning)
• Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery
  “The current PI is leaving the study. Study team is awaiting FDA PI change approval.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.